They are characterized by somatic bi-allelic inactivating mutations in the HNF1A (also known as TCF1) gene resulting in hepatocyte proliferation and increased lipogenesis by fatty acid synthesis and down regulation of liver-type fatty acid binding protein (LFABP), manifesting as lesional steatosis. The gene discussed is HNF1A; the disease is steatosis.